Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Researchers from the University of Colorado School of Medicine and Children's Hospital Colorado interviewed 41 low-income parents of girls ages 12-15 to determine why they didn't get the vaccine or finish the course, and included both English speakers and Spanish speakers in the study.
English-speaking parents expressed concerns over the need and safety of the vaccine, while Spanish-speaking parents said health care providers failed to explain that they needed three shots to be fully immunized. They also feared the vaccine would encourage sexual activity.
"The reasons low-income girls did not initiate or complete the HPV vaccination were strikingly different depending on whether their parents spoke English or Spanish," said study author Sean O'Leary, MD, MPH, an investigator at the Children's Outcomes Research Program, affiliated with the University of Colorado School of Medicine and Children's Hospital Colorado. "This is a safe and effective vaccine. We are seeing huge declines in HPV infection rates in the US overall and especially among those who have received the vaccine."
O'Leary presented the study, which will be published within the next several months, in San Francisco last week at IDWeek 2013, an annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association and the Pediatric Infectious Diseases Society.
He said HPV is the most commonly sexually transmitted infection in the U.S. with 75 percent of Americans infected at some point. It is also a leading cause of cervical cancer in women and throat cancer in men.
Every year, 12,000 women are diagnosed with cervical cancer. The Centers for Disease Control and Prevention (CDC) recommends all boys and girls between the ages of 11 and 12 receive the vaccination before they become sexually active.
The vaccine is given in three doses over six months. The CDC reports that 33 percent of girls overall have had the three shots while just 28 percent of those below the poverty line received the injections.
"This is a population that is statistically at a higher risk of cervical cancer," O'Leary said. "So we wanted to find out why they weren't getting their shots."
Those who spoke English told investigators that they felt the risk of contracting HPV was questionable and they also worried about the safety of the vaccine.
"They wanted definitive proof that it was necessary," O'Leary said. "The Spanish-speakers had no problems with vaccine safety. But they said their providers didn't recommend it and some feared it would encourage sexual activity."
Others got the first or second dose of the vaccine but stopped there. They said a reminder system using texts or similar methods might prompt them to get the additional vaccines.
The researchers made the following recommendations:
"The HPV vaccine is one of the few tools we have that actually prevents cancer," O'Leary said. "If we can do a better job helping parents understand how important it is to have their adolescents vaccinated, cervical cancer and other HPV-related cancers may become things of the past."
The co-authors of the study are Juliana Barnard, MA, Steve Lockhart, BA, Karen Albright, PhD, Andrea Clinger, MPH, Michelle Lee, MPH, Shannon Stokley, MPH, Amanda Dempsey, MD, PhD, MPH and Allison Kempe, MD, MPH.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Cervical Cancer / HPV Vaccine category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
University of Colorado Denver. "Barriers to HPV vaccination." Medical News Today. MediLexicon, Intl., 16 Oct. 2013. Web.
4 Dec. 2013. <http://www.medicalnewstoday.com/releases/267442>
University of Colorado Denver. (2013, October 16). "Barriers to HPV vaccination." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/267442.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.